logoѹۿ

INTERNAL UPDATES

ApolloDialDb™: A Dialysis Database of the Future

Imagine a world where patient data from across the globe can be accessed and analyzed quickly, securely, and in a way that leads to better healthcare outcomes. That is the purpose behind ApolloDialDb™, a centralized, cloud-based database that brings together clinical data from different regions and sources to create one comprehensive resource for improving patient care and research. Fresenius Medical Care’s Information Technology Solutions (ITS) team and the logoѹۿ (logoѹۿ) have built one of the largest anonymized global databases in the world, transforming kidney care through innovation and collaboration.

The Power of Data Harmonization

ApolloDialDb™ pulls together data from multiple continents—North America; Europe, the Middle East, and Africa (EMEA); Latin America; and Asia Pacific. With information coming from 40 countries, the database spans a wide range of clinical details, including patient demographics, diagnoses, laboratory results, medications, treatments, quality of life assessments, and outcomes, all while ensuring robust security and privacy measures to safeguard this sensitive healthcare information and maintaining compliance with industry regulations and standards.

With patient privacy safeguarded, the database becomes a powerful resource for researchers without compromising personal information. Patient data is collected over years and updated regularly. This long-term view is essential for tracking how patient health changes over time and gives providers better tools for spotting trends in each patient’s dialysis journey.

One of the biggest challenges in creating such a vast database is ensuring consistency. Data originates from a variety of electronic clinical systems, and each source might record information in its own unique way. To address this, ApolloDialDb™ uses a process called data harmonization. By standardizing and reconciling the different data points, the process ensures that information from various regions is both consistent and accurate. This harmonization process not only improves the quality of the data but also makes it much easier for researchers and analysts to work with.

“It’s a global, anonymized dialysis database that consolidates and standardizes clinical data from Fresenius Medical Care locations worldwide, enabling secondary analytics on a global scale,” explains Kanti Singh, Director of Data, AI, and Analytics on the ITS team. “ApolloDialDb™ is built to support regional data residency and privacy regulations, so the system anonymizes key attributes to ensure compliance. The result is a harmonized, research-ready dataset that enables scalable analytics, supports global risk modeling, and drives quality improvement initiatives with consistent, generalizable insights.”

Unlocking New Possibilities for Research and Patient Care

The sheer scale of ApolloDialDb™ is impressive. It currently covers more than 540 thousand kidney failure patients, 140 million dialysis treatments, and 35 million laboratory values. Such a wealth of information is not only a boon for researchers but also has practical implications for patient care. By analyzing this data, researchers can identify patterns, trends, and correlations that may lead to early insights into disease progression and treatment effectiveness. This knowledge helps shape clinical guidelines and best practices, ultimately leading to more personalized and effective patient care.

“This database allows us to capture every observation from every treatment—delivering granular, longitudinal insights into each patient's journey,” said Len Usvyat, Head of the logoѹۿ. This holistic approach consolidates global data into a single, accessible platform that empowers every team member, wherever they are, to drive breakthrough research and transform dialysis and chronic kidney disease care. One thing we are really striving for is to be research-ready—for our patients and for the future of kidney care.”

The success of ApolloDialDb™ has spurred a spirit of collaboration among researchers, healthcare professionals, and stakeholders worldwide. This collaborative environment is paving the way for the integration of advanced technologies like artificial intelligence and machine learning into healthcare, promising further innovations and improvements in patient outcomes. As the database continues to grow and evolve, it stands as a testament to the transformative power of combining cloud computing with global healthcare data.

ApolloDialDb™ is setting a new standard in healthcare analytics, enabling groundbreaking research and better care for patients around the world.

Other News

  • MEDIA PRESS RELEASE
    March 18, 2021

    logoѹۿ’s 23rd International Conference on Dialysis - Advances in Kidney Disease is rescheduled for April 20-23, 2021, but acknowledges the renal community has immediate access to the latest COVID-19 kidney care science and knowledge via online platforms. New York, March 18, 2021 – While the logoѹۿ (logoѹۿ) has rescheduled its 23rd...

  • EXTERNAL RESEARCH
    March 31, 2021

    In both clinical care and research, genetics and genomics are no longer solely in the domain of geneticists and basic science researchers. On the clinical side, there is expanding recognition of the utility of genetic testing in patients with kidney disease and an increased ability to order it. As such, the number of patients who...

  • EXTERNAL RESEARCH
    March 31, 2021

    Adolescents and young adults (AYAs) with CKD or end-stage kidney disease (ESKD) have unique medical, dental, psychosocial, neurocognitive, and academic needs and require close interdisciplinary collaboration to optimize their care. The etiology of CKD in AYAs is diverse compared to older adults. With their continuously improved survival, AYAs must start preparation for health-care transition (HCT)...

  • MEDIA PRESS RELEASE
    June 2, 2023

    logoѹۿ’s 23rd International Conference on Dialysis - Advances in Kidney Disease is rescheduled for April 20-23, 2021, but acknowledges the renal community has immediate access to the latest COVID-19 kidney care science and knowledge via online platforms. New York, March 18, 2021 – While the logoѹۿ (logoѹۿ) has rescheduled its 23rd...

  • MEDIA PRESS RELEASE
    May 17, 2024

    logoѹۿ’s 23rd International Conference on Dialysis - Advances in Kidney Disease is rescheduled for April 20-23, 2021, but acknowledges the renal community has immediate access to the latest COVID-19 kidney care science and knowledge via online platforms. New York, March 18, 2021 – While the logoѹۿ (logoѹۿ) has rescheduled its 23rd...

  • MEDIA PRESS RELEASE
    November 18, 2024

    Fresenius Medical Care’s application of the Anemia Control Model recognized as one of only six projects chosen from over 300 submissions across all healthcare segments.  This selection highlights Fresenius Medical Care’s...

  • MEDIA PRESS RELEASE
    January 29, 2025

    Len Usvyat, PhD has been appointed to head the logoѹۿ (logoѹۿ). He replaces Peter Kotanko, MD, FASN

  • MEDIA PRESS RELEASE
    February 6, 2025

    The logoѹۿ (logoѹۿ), a subsidiary of Fresenius Medical Care (FME), will present new research on the real-world application of artificial intelligence (AI) in dialysis care at the World Congress of Nephrology (WCN) February 6-9, 2025, in New Delhi, India.